Latest Industry Press Releases More...

We bring you the latest pharmaceutical press releases in our pharmaceutical Industry Press Releases section to help our clients gain great exposure on industry happenings. Know about mergers, deals, technology release, and other information first hand from press conferences of industry leaders with our Global pharmaceuticals Industry Press Releases.

Global pharmaceutical company Mylan N.V.  today announced the U.S. launch of Bivalirudin for Injection, 250 mg single-dose vial, a generic version of Angiomax® from The Medicines Company. The product is a direct thrombin inhibitor indicated for use as an anticoagulant in patients. Mylan is offering Bivalirudin for Injection, 250 mg…

Shamrock Biopharmaceutical, a biopharmaceutical company committed to the development of innovative and transformative biopharmaceuticals, today announced the first patient in the SCB-313 Phase I clinical trial in Australia. The drug is an innovative recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-trimeric fusion protein used to treat cancer patients with malignant…

Tuesday, Jun 19, 2018

Technology growth and innovation through effective scouting, corporate venture and open innovation principles. As the technological market speeds ahead, many challenges directly impact innovation leaders. Capitalising on external innovation and strategic partnerships is crucial to gain and maintain a competitive advantage. ENG’s 8th annual summit will bring leading innovation, techscout…

Novartis today announced 14-month results from the pivotal JULIET clinical trial showing ongoing durable responses are achievable with Kymriah® (tisagenlecleucel) when administered to adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL). The overall response rate (ORR) was 52% (95% confidence interval [CI], 41% - 62%), among…

The U.S. Food and Drug Administration today approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. "The FDA is taking new steps to advance the development of improved treatments for opioid use disorder, and to make sure…

 Corium International, Inc., a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that the United States Patent and Trademark Office (PTO) has issued a cornerstone patent related to the company’s Corplex Donepezil Transdermal Delivery System (TDS), a once-weekly patch that delivers…

Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., today announced the launch of the Shanghai Lung Cancer Innovation QuickFire Challenge to identify new solutions for lung health and to combat lung cancer in China and around the world. Avrum Spira, Global Head, Lung Cancer Initiative, Johnson…

 STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, congratulates its partner Ascletis for receiving approval from National Drug Administration of China (CNDA, former CFDA) of its Category 1 new drug, Ganovo® (also known as Danoprevir or ASC08), to treat viral hepatitis C. Ganovo® is the first Direct-acting Anti-viral Agent…

AbCellera Biologics Inc. today announced the successful completion of the first phase of its collaboration with Denali Therapeutics Inc. Under the collaboration, AbCellera applied its single-cell screening technology to discover hundreds of novel monoclonal antibodies with specific binding properties against a genetically-validated target for neurodegenerative disease. Denali’s CEO, Ryan Watts,…

CStone Pharmaceuticals  today announced that two pivotal Phase II studies exploring the efficacy and safety of CS1001 in patients with natural killer cell/T-cell lymphoma (CS1001-201) and classical Hodgkin's lymphoma (CS1001-202) have been initiated, and have respectively enrolled and dosed the first patient. CS1001 is China's first fully human, full-length, IgG4…

loader